CHRNB2 and fragile X syndrome: Analysis of differently expressed genes in cholinergic synaptic pathway showed high variation in CHRNB2 expression and a tendency toward higher expression levels in FXS NPCs without epilepsy than in control NPCs and FXS NPCs with epilepsy.